2-Cyano-5-Flurobenzyl Bromide CAS 421552-12-7 Puritas ≥99.0% (HPLC) Trelagliptin Succinate Intermedia Factory
Commercial Supple Trelagliptin Succinate Related Intermedia:
6-Chloro-3-Methyluracil CAS 4318-56-3
2-Cyano-5-Flurobenzyl Bromide CAS 421552-12-7
(R)-(-)-3-Aminopiperidine dihydrochloride CAS 334618-23-4
Trelagliptin Succinate Intermediate-int D CAS 865759-246
Trelagliptin Succinate CAS 1029877-94-8
Please contact: alvin@ruifuchem.com
Nomen chemicum | 2-Cyano-5-Flurobenzyl Bromide |
Synonyma | 2-(Bromomethyl) -4-Fluorobenzonitrile |
CAS Number | 421552-12-7 |
CATTUS Number | RF-PI143 |
Stock Status | In Stock, Productio Ascendite ad Tons |
Formulae hypotheticae | C8H5BrFN |
M. Pondus | 214.03 |
Liquescens punctum | 67.0 ad 71.0℃ |
Sensitiva | umorem Sensitivum |
Solubilitas | Solutum in Methanol |
Brand | Ruifu Chemical |
Item | Specifications |
Aspectus | White ad Off-Yellow pulveris |
Puritas / Analysis Methodus | ≥99.0% (HPLC) |
Humor (KF) | ≤0.50% |
Residere in Ignition | ≤0.30% |
una immunditia | ≤0.50% |
Totalis immunditias | ≤1.00% |
1 H NMR Spectrum | Congruunt cum Structure |
Test Standard | Enterprise Standard |
Consuetudinem | Trelagliptin Succinate (CAS: 1029877-94-8) Intermedia |
sarcina: Utrem, aluminium foil, pera, cardboard tympanum, 25kg/Drum, vel secundum exigentiam emptoris.
Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine, umore et peste infestatione.
![1](https://a395.goodao.net/uploads/15.jpg)
![2](https://a395.goodao.net/uploads/23.jpg)
Shanghai Ruifu Chemical Co., Ltd. est praecipuum fabricam et supplementum 2-Cyano-5-Flurobenzyl Bromide (CAS: 421552-12-7) magna qualitate, late in synthesi organica adhibita, synthesis intermedia pharmaceutica et medicamenta pharmaceutica activa. (API) synthesis.2-Cyano-5-Flurobenzyl Bromide adhiberi potest in synthesi Trelagliptin Succinate (CAS: 1029877-94-8).Trelagliptin Succinatus selectivus est, diu agens dipeptidylum peptidase-4 (DPP-4) inhibitor.Agens antidiabetic.Inhibitor ore activo DPP-4 qui efficit amet ac peraeque signanter emendationes glycemicae moderationis patientis cum 2 diabete typus.Trelagliptin Succinatus usus in Iaponia mense Martio MMXV probatus est.